SJSaumya Jain

Saumya Jain

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Saumya Jain has a total of 29 co-authors. Here are the top co-authors by number of shared publications:

  • Nasim Annabi

    Department of Chemical Engineering, Northeastern University, Boston, MA, 02115, USA; Biomaterials Innovation Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA; Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA

    4 shared publications
  • Anthony Steven Weiss

    Charles Perkins Centre, University of Sydney, Camperdown, NSW 2006, Australia

    1 shared publication
  • Arpita Roy

    Department of Chemistry and Chemical Biology, IIT (ISM), Dhanbad, India

    1 shared publication
  • Avijit Baidya

    Department of Chemical and Biomolecular Engineering University of California Los Angeles Los Angeles CA 90095 USA

    1 shared publication
  • Claire Elsa Meyer

    Department of Chemistry, University of Basel, Mattenstrasse 24a, 4058, Basel, Switzerland

    1 shared publication
  • George Z. Cheng

    Division of Pulmonary Critical Care and Sleep Medicine Department of Medicine University of California San Diego La Jolla CA 92093 USA

    1 shared publication

Latest Publications

  • Open Access

    Molecular Design of a Naturally Derived Hemostatic Sealant with Prolonged Antimicrobial Activity for Repairing Elastic Organ Injuries

    by Saumya Jain, Avijit Baidya, Joshua A. Boys, George Z. Cheng, Taichiro Imahori, Naoki Kaneko, Nasim Annabi

    Hemorrhaging injuries on dynamic internal organs present significant clinical burdens due to their complex nature. To address therapeutic challenges, an injectable, photocrosslinkable, and multifunctional bioadhesive hydrogel comprising methacrylated gelatin (GelMAG), methacrylated dopamine (DMA), and poly(diallyldimethylammonium chloride) (pDDA), named GDP, is engineered. The hydrogel combined underwater adhesion, antimicrobial activity, and hemostatic performance with high elasticity, biomimetic stiffness, and biocompatibility. The GDP hydrogel displayed >200% elongation and ≈50 kPa Young's modulus in tensile tests. The bioadhesive strongly adhered (>40 kPa strength) to skin, outperforming commercial sealants Coseal and Evicel, and could seal various sizes and shapes of injuries created on explanted pig lungs. Broad‐spectrum and long‐term in vitro antibacterial activity is noted. During in vivo rat liver puncture and tail amputation, GDP achieved significantly reduced blood loss (≈65%) compared to commercial hemostat Surgicel in some cases. In a clinically relevant porcine lung laceration model, GDP sealed large defects and reduced blood loss by 45–55% compared to Surgicel and hemostatic sealant TISSEEL. It also supported enhanced wound closure and tissue regeneration with minimal inflammation. Ultimately, these findings showcased the potential of GDP to act as an elastic, antibacterial, and hemostatic sealant for the repair of multi‐dimensional traumatic injuries on soft, dynamic tissues.


  • Rapid closure and hemostasis of ruptured soft tissues using a modified human tropoelastin-based sealant in preclinical models

    by Mahsa Ghovvati, Saumya Jain, George Z. Cheng, Naoki Kaneko, Joshua A. Boys, Taichiro Imahori, Tess De Maeseneer, Reihaneh Haghniaz, Robert B. Cameron, Anthony S. Weiss, et al.

    Treatment of injuries to soft elastic organs is often hindered by challenging anatomical features and limitations of existing sealant materials, which may lack adequate tissue adhesion, elasticity, biocompatibility, and effective hemostatic properties. To address these clinical challenges, we developed an injectable elastic sealant formulated with methacryloyl-modified human recombinant tropoelastin (MeTro) and Laponite silicate nanoplatelets (SNs). We optimized the hydrogel formulation for mechanical properties, adhesion, biocompatibility, and hemostatic properties and used visible light for cross-linking to improve safety. MeTro/SN hydrogels had increased tissue adhesion strength and burst pressure in vitro and ex vivo compared with MeTro alone or commercial sealants. The addition of SNs to the hydrogels facilitated faster blood clotting in vitro without increasing hemolysis. Applied to incisional injuries on rat lungs or aortas, MeTro/SN had burst pressures comparable to those of native tissue and greater than those of MeTro after a 7-day in vivo application. On porcine lungs, MeTro/SN also supported effective lung sealing and burst pressure similar to native lung 14 days after injury sealing. In a rodent tail hemostasis model, MeTro/SN reduced bleeding compared with MeTro. In an injured porcine lung model, early hemostasis was better than the tested commercial sealants. The results demonstrated that MeTro/SN provided effective tissue sealing and promoted hemostasis in a time frame that minimized blood loss without causing a major inflammatory response. These findings highlight the translational potential of our engineered sealant with biomimetic mechanics, durable tissue adhesion, and rapid hemostasis as a multipronged approach for the sealing and repair of traumatic injuries to soft organs.


  • Top Cited Papers

    Advances in conducting nanocomposite hydrogels for wearable biomonitoring

    by Arpita Roy, Ronak Afshari, Saumya Jain, Yuting Zheng, Min-Hsuan Lin, Shea Zenkar, Junyi Yin, Jun Chen, Nicholas A. Peppas, Nasim Annabi

    Recent advancements in wearable biosensors and bioelectronics highlight biocompatible conducting nanocomposite hydrogels as key components for personalized health devices and soft electronics.


  • Open Access

    Human Skeletal Muscle Myoblast Culture in Aligned Bacterial Nanocellulose and Commercial Matrices

    by Melina Mastrodimos, Saumya Jain, Maryam Badv, Jun Shen, Hossein Montazerian, Claire E. Meyer, Nasim Annabi, Paul S. Weiss

    Bacterial nanocellulose (BNC) is a durable, flexible, and dynamic biomaterial capable of serving a wide variety of fields, sectors, and applications within biotechnology, healthcare, electronics, agriculture, fashion, and others. BNC is produced spontaneously in carbohydrate-rich bacterial culture media, forming a cellulosic pellicle via a nanonetwork of fibrils extruded from certain genera. Herein, we demonstrate engineering BNC-based scaffolds with tunable physical and mechanical properties through postprocessing. Human skeletal muscle myoblasts (HSMMs) were cultured on these scaffolds, and in vitro electrical stimulation was applied to promote cellular function for tissue engineering applications. We compared physiologic maturation markers of human skeletal muscle myoblast development using a 2.5-dimensional culture paradigm in fabricated BNC scaffolds, compared to two-dimensional (2D) controls. We demonstrate that the culture of human skeletal muscle myoblasts on BNC scaffolds developed under electrical stimulation produced highly aligned, physiologic morphology of human skeletal muscle myofibers compared to unstimulated BNC and standard 2D culture. Furthermore, we compared an array of metrics to assess the BNC scaffold in a rigorous head-to-head study with commercially available, clinically approved matrices, Kerecis Omega3 Wound Matrix (Marigen) and Phoenix as well as a gelatin methacryloyl (GelMA) hydrogel. The BNC scaffold outcompeted industry standard matrices as well as a 20% GelMA hydrogel in durability and sustained the support of human skeletal muscle myoblasts in vitro. This work offers a robust demonstration of BNC scaffold cytocompatibility with human skeletal muscle cells and sets the basis for future work in healthcare, bioengineering, and medical implant technological development.